| Literature DB >> 35774567 |
Tomás Caycho-Rodríguez1, Pablo D Valencia2, José Ventura-León1, Lindsey W Vilca3, Carlos Carbajal-León1, Mario Reyes-Bossio4, Michael White5, Claudio Rojas-Jara6, Roberto Polanco-Carrasco7, Miguel Gallegos6,8,9,10, Mauricio Cervigni9,10,11, Pablo Martino9,10, Diego Alejandro Palacios12, Rodrigo Moreta-Herrera13, Antonio Samaniego-Pinho14, Marlon Elías Lobos-Rivera15, Andrés Buschiazzo Figares16, Diana Ximena Puerta-Cortés17, Ibraín Enrique Corrales-Reyes18, Raymundo Calderón19, Bismarck Pinto Tapia20, Walter L Arias Gallegos21, Olimpia Petzold22,23.
Abstract
Aims: Over the past 2 years, the vaccine conspiracy beliefs construct has been used in a number of different studies. These publications have assessed the determinants and outcomes of vaccine conspiracy beliefs using, in some cases, pooled data from different countries, and compared the results across these contexts. However, studies often do not consider measurement invariance as a necessary requirement for comparative analyses. Therefore, the aim of this study was to develop and evaluate the cross-cultural MI of the COVID-19 Vaccine Conspiracy Beliefs Scale (COVID-VCBS) in 12 Latin American countries.Entities:
Keywords: COVID-19; Latin America; conspiracy beliefs; invariance; vaccines
Mesh:
Substances:
Year: 2022 PMID: 35774567 PMCID: PMC9237359 DOI: 10.3389/fpubh.2022.908720
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Sociodemographic Information of the Study Sample.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | |||||||||||||
| Male | 108 (29.8) | 143 (25.2) | 139 (30.7) | 139 (30.1) | 103 (30.8) | 127 (29.0) | 200 (26.8) | 123 (29.3) | 153 (31.6) | 125 (30) | 98 (30.4) | 120 (30.5) | 109 (28.2) |
| Female | 255 (70.3) | 421 (74.3) | 314 (69.3) | 322 (69.7) | 231 (69.2) | 311 (71.0) | 546 (73.1) | 297 (70.7) | 331 (68.4) | 292 (70) | 224 (69.6) | 273 (69.5) | 276 (71.5) |
| Other | 0 (0.0) | 3 (0.5) | 0 (0.0) | 1 (0.2) | 0 (0.0) | 0 (0.0) | 1 (0.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.3) |
| Marital status | |||||||||||||
| Single | 198 (54.6) | 247 (43.6) | 264 (58.3) | 368 (79.7) | 194 (58.1) | 289 (66) | 502 (67.2) | 172 (41.0) | 407 (84.1) | 258 (61.9) | 251 (78) | 227 (57.8) | 166 (43.0) |
| Married | 74 (20.4) | 223 (39.3) | 99 (21.9) | 61 (13.2) | 64 (19.2) | 98 (22.4) | 167 (22.4) | 179 (42.6) | 57 (11.8) | 94 (22.5) | 45 (14.0) | 73 (18.6) | 146 (37.8) |
| Cohabiting | 45 (12.4) | 31 (5.5) | 61 (13.5) | 23 (5.0) | 65 (19.5) | 22 (5.0) | 40 (5.4) | 31 (7.4) | 7 (1.5) | 45 (10.8) | 21 (6.5) | 63 (16.0) | 22 (5.7) |
| Divorced | 28 (7.7) | 58 (10.2) | 24 (5.3) | 8 (1.7) | 8 (2.4) | 25 (5.7) | 25 (3.4) | 29 (6.9) | 13 (2.7) | 13 (3.1) | 4 (1.2) | 26 (6.6) | 44 (11.4) |
| Widowed | 18 (5.0) | 8 (1.4) | 5 (1.1) | 2 (0.4) | 3 (0.9) | 4 (0.9) | 13 (1.7) | 9 (2.1) | 0 (0.0) | 7 (1.7) | 1 (0.3) | 4 (1.0) | 8 (2.1) |
| Employment | |||||||||||||
| Stable job | 165 (45.5) | 239 (42.2) | 253 (55.8) | 124 (26.8) | 190 (56.9) | 154 (35.2) | 367 (49.1) | 258 (61.4) | 158 (32.6) | 254 (60.9) | 119 (37.0) | 264 (67.2) | 227 (58.8) |
| Temporary job | 59 (16.3) | 159 (28.0) | 64 (14.1) | 104 (22.5) | 28 (8.4) | 103 (23.5) | 122 (16.3) | 87 (20.7) | 88 (18.2) | 85 (20.4) | 122 (37.9) | 51 (13.0) | 58 (15.0) |
| Unemployed | 87 (24.0) | 150 (26.5) | 125 (27.6) | 218 (47.2) | 114 (34.1) | 159 (36.3) | 218 (29.2) | 44 (10.5) | 226 (46.7) | 70 (16.8) | 76 (23.6) | 68 (17.3) | 67 (17.4) |
| Retired | 52 (14.3) | 19 (3.4) | 11 (2.4) | 16 (3.5) | 2 (0.6) | 22 (5.0) | 40 (5.4) | 31 (7.4) | 12 (2.5) | 8 (1.9) | 5 (1.6) | 10 (2.5) | 34 (8.8) |
| Education | |||||||||||||
| University | 159 (43.8) | 418 (73.7) | 266 (58.7) | 120 (26.0) | 167 (50.0) | 189 (43.2) | 170 (22.8) | 267 (63.6) | 128 (26.4) | 269 (64.5) | 135 (41.9) | 176 (44.8) | 260 (67.4) |
| University (incomplete) | 137 (37.7) | 85 (15) | 106 (23.4) | 127 (27.5) | 152 (45.5) | 140 (32.0) | 262 (35.1) | 98 (23.3) | 276 (57.0) | 112 (26.9) | 105 (32.6) | 127 (32.3) | 73 (18.9) |
| Vocational school (complete) | 17 (4.7) | 42 (7.4) | 43 (9.5) | 53 (11.5) | 7 (2.1) | 11 (2.5) | 31 (4.1) | 19 (4.5) | 35 (7.2) | 7 (1.7) | 29 (9.0) | 26 (6.6) | 19 (4.9) |
| Vocational school (incomplete) | 2 (0.6) | 3 (0.5) | 6 (1.3) | 3 (0.6) | 2 (0.6) | 5 (1.1) | 2 (0.3) | 0 (0.0) | 1 (0.2) | 1 (0.2) | 7 (2.2) | 4 (1.0) | 1 (0.3) |
| High school (complete) | 40 (11.0) | 15 (2.6) | 28 (6.2) | 141 (30.5) | 5 (1.5) | 78 (17.8) | 164 (22.0) | 30 (7.1) | 39 (8.1) | 24 (5.8) | 39 (12.1) | 36 (9.2) | 28 (7.3) |
| Incomplete high school or lower | 8 (2.2) | 4 (0.7) | 4 (0.9) | 18 (3.9) | 1 (0.3) | 15 (3.4) | 118 (15.8) | 6 (1.4) | 5 (1.0) | 4 (1.0) | 7 (2.2) | 24 (6.1) | 5 (1.3) |
| Had COVID-19 | |||||||||||||
| No | 180 (49.6) | 247 (43.6) | 368 (81.2) | 214 (46.3) | 158 (47.3) | 226 (51.6) | 348 (46.6) | 285 (67.9) | 256 (52.9) | 182 (43.6) | 90 (28.0) | 300 (76.3) | 187 (48.4) |
| Most likely not | 48 (13.2) | 53 (9.3) | 35 (7.7) | 47 (10.2) | 24 (7.2) | 31 (7.1) | 68 (9.1) | 13 (3.1) | 47 (9.7) | 27 (6.5) | 16 (5.0) | 25 (6.4) | 27 (7.0) |
| Most likely yes | 25 (6.9) | 78 (13.8) | 6 (1.3) | 73 (15.8) | 55 (16.5) | 59 (13.5) | 181 (24.2) | 25 (6.0) | 46 (9.5) | 56 (13.4) | 68 (21.1) | 7 (1.8) | 59 (15.3) |
| Yes | 110 (30.3) | 189 (33.3) | 44 (9.7) | 128 (27.7) | 97 (29.0) | 122 (27.9) | 150 (20.1) | 97 (23.1) | 135 (27.9) | 152 (36.5) | 148 (46.0) | 61 (15.5) | 113 (29.3) |
| Relative had COVID-19 | |||||||||||||
| No | 108 (29.8) | 113 (19.9) | 187 (41.3) | 115 (24.9) | 60 (18.0) | 111 (25.3) | 321 (43.0) | 98 (23.3) | 88 (18.2) | 73 (17.5) | 55 (17.1) | 223 (56.7) | 90 (23.3) |
| Yes | 255 (70.2) | 454 (80.1) | 266 (58.7) | 347 (75.1) | 274 (82.0) | 327 (74.7) | 426 (57.0) | 322 (76.7) | 396 (81.8) | 344 (82.5) | 267 (82.9) | 170 (43.3) | 296 (76.7) |
| Friend had COVID-19 | |||||||||||||
| No | 25 (6.9) | 32 (5.6) | 117 (25.8) | 70 (15.2) | 7 (2.1) | 77 (17.6) | 153 (20.5) | 16 (3.8) | 67 (13.8) | 20 (4.8) | 41 (12.7) | 129 (32.8) | 25 (6.5) |
| Yes | 338 (93.1) | 535 (94.4) | 336 (74.2) | 392 (84.8) | 327 (97.9) | 361 (82.4) | 594 (79.5) | 404 (96.2) | 417 (86.2) | 397 (95.2) | 281 (87.3) | 264 (67.2) | 361 (93.5) |
Original English version of the VCBS, Spanish version of the VCBS, Spanish version of the COVID-VCBS and English version of the COVID-VCBS.
|
|
|
|
|
|
|---|---|---|---|---|
| 1 | Vaccine safety data is often fabricated. | La información sobre la seguridad de las vacunas a menudo se inventan. | La información sobre la seguridad de las vacunas contra la COVID-19 a menudo se inventan. | Information about the safety of COVID-19 vaccines is often fabricated. |
| 2 | Immunizing children is harmful and this fact is covered up | Vacunar a los niños es perjudicial y este hecho está ocultado | Vacunar a los niños contra la COVID-19 es perjudicial y este hecho está ocultado. | Vaccinating children against COVID-19 is harmful and this fact is covered up |
| 3 | Pharmaceutical companies cover up the dangers of vaccines. | Las empresas farmacéuticas ocultan los peligros de las vacunas | Las empresas farmacéuticas ocultan los peligros de las vacunas contra la COVID-19. | Pharmaceutical companies cover up the dangers of COVID-19 vaccines |
| 4 | People are deceived about vaccine efficacy. | Se engaña a las personas sobre la eficacia de las vacunas | Se engaña a las personas sobre la eficacia de las vacunas contra la COVID-19. | People are being misled about the efficacy of COVID-19 vaccines |
| 5 | Vaccine efficacy data is often fabricated | La información sobre la eficacia de las vacunas a menudo se inventan | La información sobre la eficacia de las vacunas contra la COVID-19 a menudo se inventan. | COVID-19 Vaccine efficacy information is often fabricated |
| 6 | People are deceived about vaccine safety. | Se engaña a las personas sobre la seguridad de las vacunas | Se engaña a las personas sobre la seguridad de las vacunas contra la COVID-19. | People are deceived about COVID-19 vaccine safety |
| 7 | The government is trying to cover up the link between vaccines and autism. | El gobierno está tratando de ocultar el vínculo entre las vacunas y la aparición de otras enfermedades | El gobierno está tratando de ocultar el vínculo entre las vacunas contra la COVID-19 y la aparición de otras enfermedades | The government is trying to cover up the link between COVID-19 vaccines and autism |
This translation followed a process of forward and back translation with a focus group to review the translated Spanish version.
Figure 1Percentage of people vaccinated against COVID-19 by October 25, 2021 in participating countries based on data derived from Our World in Data (71).
Aiken's V for assessing the clarity, consistency and relevance of the COVID-VCBS items.
|
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| 1 | 2.71 | 0.47 | 0.90 | 0.75–0.97 | 2.57 | 0.65 | 0.86 | 0.69–0.94 | 2.71 | 0.47 | 0.90 | 0.75–0.97 |
| 2 | 2.50 | 0.52 | 0.83 | 0.66–0.93 | 2.21 | 0.58 | 0.74 | 0.59–0.86 | 2.21 | 0.43 | 0.74 | 0.56–0.86 |
| 3 | 2.64 | 0.74 | 0.88 | 0.72–0.96 | 2.71 | 0.73 | 0.90 | 0.75–0.97 | 2.64 | 0.74 | 0.88 | 0.72–0.96 |
| 4 | 2.36 | 0.63 | 0.79 | 0.61–0.90 | 2.43 | 0.51 | 0.81 | 0.64–0.91 | 2.50 | 0.52 | 0.83 | 0.66–0.93 |
| 5 | 2.86 | 0.36 | 0.95 | 0.81–0.99 | 2.71 | 0.61 | 0.90 | 0.75–0.97 | 2.50 | 0.76 | 0.83 | 0.66–0.93 |
| 6 | 2.57 | 0.51 | 0.86 | 0.69–0.94 | 2.79 | 0.43 | 0.93 | 0.78–0.98 | 2.79 | 0.43 | 0.93 | 0.78–0.98 |
| 7 | 2.36 | 0.63 | 0.79 | 0.61–0.90 | 2.21 | 0.58 | 0.74 | 0.56–0.86 | 2.36 | 0.63 | 0.79 | 0.61–0.90 |
M, mean; SD, standard deviation; V, Aiken's V; CI, Confidence Interval.
Item-level descriptive statistics of the COVID-VCBS items.
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| ||
| Argentina ( |
| 3.69 | 2.47 | 3.24 | 2.96 | 3.07 | 2.98 | 2.84 |
|
| 1.88 | 1.70 | 1.77 | 1.68 | 1.74 | 1.65 | 1.71 | |
|
| 0.07 | 1.02 | 0.40 | 0.54 | 0.44 | 0.52 | 0.60 | |
|
| −0.98 | 0.27 | −0.70 | −0.53 | −0.77 | −0.47 | −0.45 | |
| Bolivia ( |
| 3.73 | 3.25 | 3.88 | 3.78 | 3.56 | 3.59 | 3.56 |
|
| 1.73 | 1.74 | 1.79 | 1.81 | 1.72 | 1.71 | 1.77 | |
|
| 0.10 | 0.37 | 0.06 | 0.15 | 0.26 | 0.23 | 0.18 | |
|
| −0.78 | −0.62 | −0.76 | −0.87 | −0.68 | −0.70 | −0.79 | |
| Chile ( |
| 3.15 | 2.60 | 3.31 | 2.90 | 2.77 | 2.91 | 3.11 |
|
| 1.94 | 1.74 | 1.81 | 1.78 | 1.71 | 1.80 | 1.90 | |
|
| 0.48 | 0.95 | 0.44 | 0.68 | 0.79 | 0.67 | 0.58 | |
|
| −0.94 | 0.07 | −0.70 | −0.52 | −0.29 | −0.55 | −0.76 | |
| Colombia ( |
| 3.89 | 2.92 | 3.58 | 3.53 | 3.50 | 3.48 | 3.70 |
|
| 1.83 | 1.65 | 1.76 | 1.83 | 1.73 | 1.76 | 1.86 | |
|
| −0.05 | 0.47 | 0.15 | 0.23 | 0.20 | 0.24 | 0.13 | |
|
| −0.79 | −0.50 | −0.78 | −0.87 | −0.75 | −0.77 | −0.92 | |
| Cuba ( |
| 3.25 | 1.94 | 2.91 | 2.90 | 2.95 | 2.74 | 2.65 |
|
| 1.87 | 1.43 | 1.73 | 1.81 | 1.78 | 1.68 | 1.70 | |
|
| 0.29 | 1.55 | 0.54 | 0.61 | 0.57 | 0.69 | 0.83 | |
|
| −1.00 | 1.96 | −0.58 | −0.68 | −0.70 | −0.51 | −0.09 | |
| Ecuador ( |
| 4.05 | 3.20 | 3.93 | 3.66 | 3.66 | 3.63 | 3.72 |
|
| 1.90 | 1.87 | 1.90 | 1.93 | 1.89 | 1.91 | 1.86 | |
|
| −0.08 | 0.45 | 0.06 | 0.16 | 0.19 | 0.25 | 0.13 | |
|
| −0.95 | −0.79 | −0.96 | −1.06 | −0.94 | −0.91 | −0.89 | |
| El Salvador ( |
| 4.14 | 3.72 | 4.07 | 3.82 | 3.87 | 3.86 | 4.00 |
|
| 1.88 | 1.87 | 1.76 | 1.83 | 1.78 | 1.80 | 1.87 | |
|
| −0.16 | 0.05 | −0.09 | 0.05 | −0.02 | −0.01 | −0.07 | |
|
| −0.89 | −0.92 | −0.72 | −0.85 | −0.76 | −0.80 | −0.90 | |
| Guatemala ( |
| 4.15 | 3.07 | 3.88 | 3.54 | 3.73 | 3.62 | 3.53 |
|
| 1.91 | 1.83 | 1.86 | 1.86 | 1.87 | 1.83 | 1.86 | |
|
| −0.19 | 0.44 | 0.06 | 0.21 | 0.16 | 0.22 | 0.31 | |
|
| −1.01 | −0.75 | −0.90 | −0.92 | −0.92 | −0.83 | −0.80 | |
| Mexico ( |
| 3.64 | 2.67 | 3.09 | 2.95 | 2.98 | 2.88 | 3.11 |
|
| 1.90 | 1.67 | 1.72 | 1.80 | 1.73 | 1.69 | 1.78 | |
|
| 0.12 | 0.67 | 0.41 | 0.55 | 0.49 | 0.53 | 0.33 | |
|
| −0.99 | −0.39 | −0.64 | −0.64 | −0.64 | −0.54 | −0.89 | |
| Paraguay ( |
| 3.70 | 2.74 | 3.21 | 3.06 | 3.16 | 3.12 | 3.28 |
|
| 1.97 | 1.67 | 1.73 | 1.74 | 1.75 | 1.74 | 1.72 | |
|
| 0.16 | 0.74 | 0.40 | 0.60 | 0.48 | 0.57 | 0.30 | |
|
| −1.10 | −0.12 | −0.61 | −0.40 | −0.55 | −0.38 | −0.58 | |
| Peru ( |
| 4.16 | 3.46 | 3.99 | 3.93 | 3.93 | 3.98 | 3.88 |
|
| 1.82 | 1.75 | 1.73 | 1.81 | 1.69 | 1.72 | 1.76 | |
|
| −0.20 | 0.15 | −0.13 | −0.09 | −0.18 | −0.18 | −0.09 | |
|
| −0.78 | −0.71 | −0.72 | −0.83 | −0.70 | −0.72 | −0.74 | |
| Uruguay ( |
| 3.93 | 3.49 | 4.03 | 3.66 | 3.54 | 3.70 | 3.55 |
|
| 1.92 | 1.76 | 1.83 | 1.87 | 1.83 | 1.91 | 1.86 | |
|
| 0.09 | 0.29 | 0.03 | 0.25 | 0.30 | 0.20 | 0.20 | |
|
| −0.98 | −0.58 | −0.84 | −0.88 | −0.79 | −0.99 | −0.90 | |
| Venezuela ( |
| 3.59 | 3.33 | 3.76 | 3.32 | 3.37 | 3.37 | 3.74 |
|
| 1.98 | 1.91 | 1.94 | 1.88 | 1.90 | 1.93 | 1.95 | |
|
| 0.23 | 0.37 | 0.16 | 0.47 | 0.38 | 0.42 | 0.18 | |
|
| −1.10 | −0.87 | −1.07 | −0.79 | −0.91 | −0.89 | −1.03 | |
| Overall ( |
| 3.79 | 3.04 | 3.64 | 3.42 | 3.42 | 3.40 | 3.48 |
|
| 1.91 | 1.81 | 1.83 | 1.86 | 1.81 | 1.82 | 1.86 | |
|
| 0.05 | 0.51 | 0.17 | 0.31 | 0.29 | 0.31 | 0.25 | |
|
| −1.00 | −0.65 | −0.85 | −0.87 | −0.83 | −0.81 | −0.88 | |
M, Mean; SD, Standard Deviation; g1, Skewness; g2, Kurtosis.
Single-group confirmatory factor analyses and internal consistency reliability of the COVID-VCBS.
|
|
|
|
|
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
| Argentina | 30.48 | 14 | 0.007 | 0.98 | 0.97 | 0.06 | 0.03 | 0.49 | 0.61 | 0.73 | 0.88 | 0.86 | 0.90 | 0.70 | 0.89 | 0.89 |
| Bolivia | 48.40 | 14 | <0.001 | 0.97 | 0.95 | 0.07 | 0.03 | 0.51 | 0.55 | 0.74 | 0.87 | 0.84 | 0.88 | 0.70 | 0.89 | 0.89 |
| Chile | 40.83 | 14 | <0.001 | 0.98 | 0.97 | 0.07 | 0.02 | 0.62 | 0.72 | 0.82 | 0.89 | 0.89 | 0.93 | 0.80 | 0.93 | 0.93 |
| Colombia | 54.26 | 14 | <0.001 | 0.96 | 0.94 | 0.08 | 0.04 | 0.52 | 0.59 | 0.78 | 0.87 | 0.86 | 0.91 | 0.78 | 0.91 | 0.91 |
| Cuba | 17.55 | 14 | 0.228 | 1.00 | 0.99 | 0.03 | 0.02 | 0.70 | 0.58 | 0.81 | 0.91 | 0.90 | 0.92 | 0.75 | 0.92 | 0.93 |
| Ecuador | 47.13 | 14 | <0.001 | 0.96 | 0.95 | 0.07 | 0.03 | 0.46 | 0.69 | 0.80 | 0.86 | 0.80 | 0.86 | 0.87 | 0.91 | 0.91 |
| El Salvador | 60.23 | 14 | <0.001 | 0.96 | 0.95 | 0.07 | 0.03 | 0.44 | 0.55 | 0.69 | 0.84 | 0.82 | 0.86 | 0.71 | 0.87 | 0.87 |
| Guatemala | 53.16 | 14 | <0.001 | 0.95 | 0.93 | 0.08 | 0.03 | 0.41 | 0.58 | 0.73 | 0.86 | 0.79 | 0.87 | 0.72 | 0.87 | 0.88 |
| Mexico | 41.47 | 14 | <0.001 | 0.97 | 0.96 | 0.06 | 0.03 | 0.45 | 0.61 | 0.77 | 0.87 | 0.84 | 0.89 | 0.78 | 0.89 | 0.90 |
| Paraguay | 15.25 | 14 | 0.361 | 1.00 | 1.00 | 0.01 | 0.02 | 0.46 | 0.66 | 0.78 | 0.84 | 0.81 | 0.85 | 0.76 | 0.89 | 0.89 |
| Peru | 41.12 | 14 | <0.001 | 0.95 | 0.93 | 0.08 | 0.04 | 0.51 | 0.66 | 0.70 | 0.78 | 0.86 | 0.82 | 0.77 | 0.89 | 0.89 |
| Uruguay | 36.71 | 14 | 0.001 | 0.98 | 0.97 | 0.06 | 0.02 | 0.63 | 0.78 | 0.86 | 0.91 | 0.90 | 0.92 | 0.81 | 0.94 | 0.94 |
| Venezuela | 43.91 | 14 | <0.001 | 0.97 | 0.95 | 0.07 | 0.03 | 0.49 | 0.63 | 0.78 | 0.87 | 0.90 | 0.91 | 0.66 | 0.90 | 0.90 |
| Overall | 339.68 | 14 | <0.001 | 0.97 | 0.96 | 0.06 | 0.02 | 0.52 | 0.64 | 0.77 | 0.87 | 0.85 | 0.89 | 0.76 | 0.90 | 0.91 |
Approximate measurement invariance of the COVID-VCBS using the alignment method.
|
|
|
|
|
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Factor loadings | 1 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | 0.996 | 0.0 |
| 2 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| 3 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| 4 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| 5 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| 6 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| 7 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| Intercepts | 1 | AR | BO | (CL) | CO | CU | EC | SV | (GT) | MX | PY | PE | (UY) | (VE) | 0.998 | 15.4 |
| 2 | AR | (BO) | CL | CO | (CU) | EC | (SV) | GT | MX | PY | PE | UY | (VE) | |||
| 3 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| 4 | AR | (BO) | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| 5 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | (UY) | VE | |||
| 6 | AR | BO | CL | CO | CU | EC | SV | GT | MX | PY | PE | UY | VE | |||
| 7 | (AR) | BO | CL | CO | (CU) | EC | SV | GT | MX | PY | PE | (UY) | (VE) | |||
| Factor means | 0.00 | 0.38 | −0.05 | 0.32 | −0.15 | 0.42 | 0.56 | 0.41 | −0.05 | 0.07 | 0.62 | 0.46 | 0.25 | |||
Non-invariant parameters are presented in parentheses. The percentage of non-invariant parameters in presented in the last column. AR, Argentina; BO, Bolivia; CL, Chile; CO, Colombia; CU, Cuba; EC, Ecuador; SV, El Salvador; GT, Guatemala; MX, Mexico; PY, Paraguay; PE, Peru; UY, Uruguay; VE, Venezuela.
Estimated parameters of the graded response model applied to the COVID-VCBS.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 1 | 1.31 | −1.44 | −0.80 | −0.27 | 0.75 | 1.38 | 2.02 |
| 2 | 1.80 | −0.68 | −0.23 | 0.23 | 1.25 | 1.65 | 2.13 |
| 3 | 2.67 | −1.09 | −0.59 | −0.59 | 0.66 | 1.09 | 1.54 |
| 4 | 4.19 | −0.83 | −0.36 | −0.36 | 0.70 | 1.05 | 1.46 |
| 5 | 3.94 | −0.88 | −0.38 | −0.38 | 0.75 | 1.11 | 1.56 |
| 6 | 4.98 | −0.83 | −0.36 | −0.36 | 0.72 | 1.08 | 1.46 |
| 7 | 2.59 | −0.93 | −0.46 | −0.46 | 0.76 | 1.17 | 1.61 |
Parameter a is the discrimination parameter, while the b parameters are difficulty parameters from item response theory.
Figure 2Item information curves of the COVID-VCBS.
Figure 3Boxplots comparing the observed scores of the COVID-VCBS across countries.